echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Interpretation of the top journal on immunization: Cancer and gender

    Interpretation of the top journal on immunization: Cancer and gender

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Gender differences in cancer incidence and disease development have been widely recognized, but the underlying immunological mechanisms are still unclear.




    • Stem-like CD8+ T cells dominate sex differences in antitumor immunity
    • Androgen receptor (AR) signaling disrupts maintenance of stem-like state in male CD8+ T cells
    • Ablation of AR signaling synergizes with T cell-based cancer immunotherapy
    • AR expression positively correlates with CD8+ T cell exhaustion in human cancers



    Stem cell-like CD8+ T cells refer to CD8+ T cells with self-renewal and proliferation ability, which express the transcription factor TCF-1 and are the key to maintaining durable anti-tumor immunity in immunotherapy



    1.


    Figure 1.


    Figure 2.


    Figure 3.


    Figure 4.


    Figure 5.


    Figure 6.


    Figure 7.



    CD8+ T cells mediate sex differences in tumor growth, while AR signaling regulates the transition from stem-like CD8+ T cells in males to ultimately exhausted CD8+ T cells
    .

    This study provides considerable support for AR as a potentially effective therapeutic target in cancer immunotherapy
    .
    I believe that many male students felt cold when reading this research haha.
    However, apart from the concern of "men and women are different", we can learn more highlights, which is different from the ordinary routine of "dry digging and then wet verification".
    , The author starts from the wet experiment, interlocks each other, lays a solid foundation, and finally validates the data through mining data, connecting the previous and the next, and finally sublimates from the mouse model data to the human data of tumor patients, which is also the reason why the author can publish the top journal of immunization
    .

    Learn more dry goods to give birth to trust people, send high scores and good articles, I believe you can too!

    END

    Don't want to miss the hotspots and technologies every day.
    Welcome everyone to add students and people to write for the star recommendation▎The moon is a bit round typesetting▎CY.
    Literature▎Yang, C.
    , Jin, J.
    , Yang, Y.
    , Sun, H.
    , Wu, L.
    , Shen, M.
    , Hong, X.
    , Li, W.
    , Lu, L.
    , Cao, D.
    , et al.
    (2022).
    Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity.
    Immunity 55, 1268-1283 e1269.

    Recommended in the past

    Character topic

    • A full summary of academician Dong Chen's research results

    • A comprehensive collection of research results of Mr.
    Zhang Zemin's series


    Immunization Topics

    • The second district immunotherapy pure information mining

    • 6+ multi-omics immunotherapy


    space metabolism

    • Single-cell sequencing combined with spatial transcriptome sequencing

    • Space metabolism + drug resistance


    Iron Death Topic

    • Iron Death Article Summary

    • Classic iron death, and new ideas


    m6A Topic

    • Integrated bioinformatics analysis of m6A regulators

    • The same m6A gliomas are getting higher and higher


    Research acceleration

    • How bioinformatics can accelerate research projects

    • Essential skills for clinical research wet experiments


    irAEs Topic

    • irAEs: Overview

    • irAEs: Shengxin signatur


    For more information on Shengxin analysis questions: 18501230653 (same number on WeChat)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.